Cloud Platform Database Upgrade for EBS

Cloud Platform Database Upgrade for EBS

Client Overview:

Clinigen Group is a global pharmaceutical and services company, specializing in providing ethical access to critical medicines. With a complex supply chain, regulatory compliance demands, and a hybrid ERP landscape combining Oracle E-Business Suite (eBS) along with various custom solutions, Clinigen sought to modernize its infrastructure and improve database performance to meet evolving business needs.

Business Challenge:

Clinigen was facing challenges with their legacy eBS database, which was running on an outdated version. The key challenges included:
Outdated Database Infrastructure: The legacy database was struggling to keep up with increasing data demands, leading to slower performance and higher risk of downtime.
Scalability Issues: The outdated database was not optimized for future growth, making it difficult for Clinigen to scale operations efficiently.
Security Concerns: As the database was no longer receiving vendor support, Clinigen faced potential security vulnerabilities and compliance risks.

Solution Provided by eAppSys:

eAppSys facilitated a seamless upgrade of Clinigen’s eBS database to the latest version, leveraging Oracle’s Autonomous Database on Oracle Cloud Infrastructure (OCI). The solution included:

Database Upgrade to Oracle Autonomous Database: eAppSys upgraded Clinigen’s legacy database to Autonomous Database on OCI, ensuring higher performance, enhanced scalability, and improved security.
Minimal Downtime and Risk: The upgrade was performed with minimal downtime, ensuring that Clinigen’s business operations continued uninterrupted during the transition.
Automated Management: The new Autonomous Database provides automatic patching, backup, and scaling, reducing the need for manual intervention and ensuring continuous operation.

Technologies Leveraged:

Autonomous Database on OCI: For a seamless upgrade and enhanced database performance, scalability, and security.

Business Impact:

Improved Database Performance: The upgrade to Oracle’s Autonomous Database significantly improved system performance, speeding up transactions and reducing operational delays.
Scalability for Growth: Clinigen’s infrastructure is now optimized to scale as their operations grow globally, allowing them to handle more data without performance degradation.
Enhanced Security: The latest version of the Autonomous Database ensures stronger security measures, protecting sensitive data and ensuring compliance with global regulations.
Reduced Operational Risk: With automatic patching and backup, Clinigen reduced the risk of database failures and downtime, ensuring business continuity.

Conclusion:

The database upgrade to Oracle Autonomous Database on OCI successfully addressed Clinigen’s challenges with outdated infrastructure. This upgrade not only enhanced performance and scalability but also future-proofed Clinigen’s database environment, ensuring they can continue to deliver life-saving medicines efficiently while staying secure and compliant.